Panacea Biotec Half Yearly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2022	Mar-2022	Sep-2021	Mar-2021	Sep-2020
Gross Sales	215.82	296.61	364.62	310.03	314.78
Excise Duty	--	--	--	--	--
Net Sales	215.82	296.61	364.62	310.03	314.78
Other Operating Income	--	--	--	--	--
Other Income	78.17	1681.92	5.26	6.74	3.32
Total Income	293.99	1978.53	369.88	316.77	318.10
Total Expenditure	299.47	314.94	360.15	293.94	255.68
PBIDT	(5.48)	1663.59	9.73	22.83	62.42
Interest	2.43	82.79	98.05	92.60	92.74
PBDT	(7.91)	1580.80	(88.32)	(69.77)	(30.32)
Depreciation	19.94	21.70	21.96	22.89	22.71
Minority Interest Before NP	--	--	--	--	--
Tax	--	400.73	--	2.29	0.03
Deferred Tax	12.59	(29.90)	0.08	(0.76)	0.40
Reported Profit After Tax	(40.44)	1188.27	(110.36)	(94.19)	(53.46)
Minority Interest After NP	--	--	--	0.04	--
Net Profit after Minority Interest	(40.44)	1188.27	(110.36)	(94.23)	(53.46)
Extra-ordinary Items	30.42	1676.21	--	--	--
Adjusted Profit After Extra-ordinary item	(70.86)	(487.94)	(110.36)	(94.23)	(53.46)
EPS (Unit Curr.)	(6.60)	193.85	(18.02)	--	(24.19)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	6.13	6.13	6.13	6.13	6.13
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(2.54)	560.87	2.67	7.36	19.83
PBDTM(%)	--	--	--	--	--
PATM(%)	(18.74)	400.62	(30.27)	(30.38)	(16.98)

QuickLinks for Panacea Biotec Ltd.